Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 470 participants.
Also called NCT01395823
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 470 participants
- Sponsor
- Dialysis Clinic, Inc.
- Registry
-
NCT01395823
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01395823. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2016-03-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients
- Condition
- End Stage Renal Disease
- Intervention (Dietary supplement)
- ergocalciferol supplementation
- Intervention (Other)
- placebo
- Lead sponsor
- Dialysis Clinic, Inc.
Record details
- Record id
cardio:ct-nct01395823- Content hash
0c143b7704deb8d242491208c11fd78064667bdb7c2e8875f9402027db52d86e